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Neuromuscular Junction Formation in Tissue-Engineered
Skeletal Muscle Augments Contractile Function
and Improves Cytoskeletal Organization
Neil R.W. Martin, PhD,1,* Samantha L. Passey, PhD,1,2,* Darren J. Player, PhD,1 Vivek Mudera, PhD,3
Keith Baar, PhD,4 Linda Greensmith, PhD,5 and Mark P. Lewis, PhD1
Neuromuscular and neurodegenerative diseases are conditions that affect both motor neurons and the under-
lying skeletal muscle tissue. At present, the majority of neuromuscular research utilizes animal models and
there is a growing need to develop novel methodologies that can be used to help understand and develop
treatments for these diseases. Skeletal muscle tissue-engineered constructs exhibit many of the characteristics of
the native tissue such as accurate fascicular structure and generation of active contractions. However, to date,
there has been little consideration toward the integration of engineered skeletal muscle with motor neurons with
the aim of neuromuscular junction (NMJ) formation, which would provide a model to investigate neuromus-
cular diseases and basic biology. In the present work we isolated primary embryonic motor neurons and
neonatal myoblasts from Sprague-Dawley rats, and cocultured the two cell types in three-dimensional tissue-
engineered fibrin hydrogels with the aim of NMJ formation. Immunohistochemistry revealed myotube for-
mation in a fascicular arrangement and neurite outgrowth from motor neuron cell bodies toward the aligned
myotubes. Furthermore, colocalization of pre- and postsynaptic proteins and chemical inhibition of spontaneous
myotube twitch indicated the presence of NMJs in the innervated constructs. When electrical field stimulation
was employed to evoke isometric contractions, maximal twitch and tetanic force were higher in the constructs
cocultured with motor neurons, which may, in part, be explained by improved myotube cytoskeletal organi-
zation in these constructs. The fabrication of such constructs may be useful tools for investigating neuro-
muscular pharmaceuticals and improving the understanding of neuromuscular pathologies.
Introduction
Neuromuscular junctions (NMJs) are a highly spe-cialized synapse in the peripheral nervous system, which
regulate skeletal muscle contraction, and consist of a pre-
synaptic motor neuron terminal, synaptic cleft, and postsyn-
aptic motor end plate.1 A number of neuromuscular and
neurodegenerative diseases impact upon the integrity of the
NMJ either at the presynaptic or postsynaptic membrane, and
consequently lead to loss of muscle mass and muscle weak-
ness.2 Furthermore, in aged individuals, degradation of ace-
tylcholine receptors (AChRs) on the postsynaptic membrane
can lead to denervation and subsequently the age-related loss
of muscle size and function.3 Current methodologies for in-
vestigating such neuromuscular pathologies rely heavily on
the use of animal models such as transgenic mice,4 which
have inherent sampling and ethical implications, or mono-
layer cell cultures,5 which fail to mimic the in vivo niche and
are limited by the inability to measure muscle function and
phenotype.
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By contrast, tissue engineering techniques can be used to
generate biomimetic model tissues in three-dimensions (3D),
which better resemble native tissues and can be used for
physiological, clinical, and pharmaceutical testing with fewer
ethical issues. Indeed, engineered constructs display many of
the same morphological characteristics as in vivo skeletal
muscle, such as the development of aligned myotubes, which
are orientated in parallel to one another and are surrounded by a
biological matrix.6,7 Furthermore, engineered muscles are ca-
pable of active contractions in response to electrical stimuli,
and exhibit positive force-frequency and accurate length-
tension relationships.8 However, although the field of skeletal
muscle tissue engineering is becoming ever more advanced,
little data exist with regard to the integration of other cell types
which are fundamental to skeletal muscle structure and func-
tion in vivo. In particular, the addition of motor neurons toward
the goal of generating NMJs has been sparsely considered.
Neuronal input is essential for optimal muscle development
and function. The absence of innervation during embryonic
development has been shown to result in the degeneration of
myotubes,9 ablation of secondary myotube development,10 and
reduction in myotube size.11 Furthermore, slow myosin heavy
chain expression is reduced in the absence of innervations,11
which in turn will affect muscle phenotype. In adult ro-
dents, neurotomy results in immediate reductions in contractile
force,12 and in spinal cord injured humans there is a quickening
of the contractile kinetics. Therefore, it is clear that the presence
ofmotor neurons and functioningNMJs regulate fiber size, type,
and maturation. As such, an engineered muscle, which is in-
nervated by motor neurons, would be expected to better repre-
sent in vivo tissue by means of improved structure and function.
Moreover, engineered skeletal muscle with a motor neuron in-
terface and NMJs would not only generate a more physiologi-
cally relevant tissue, but could also be used to help understand
the biology of the NMJ in health and disease, as well as provide
a platform to assess pharmaceutical treatments.
To date, the majority of investigations concerned with the
generation of NMJ’s in vitro have been carried out using
monolayer culture techniques. Indeed, combinations of ro-
dent and human-derived myotubes and motor neurons co-
cultured on functionalized glass coverslips have resulted in
NMJ generation as evidenced by immunolabeling of neu-
romuscular proteins and chemical inhibition of neuron-
mediated myotube contractions.13–15 Furthermore, Southam
et al. recently reported the use of microfluidic technologies
to promote axonal growth in a directed manner toward
myotube cultures, resulting in neuromuscular interactions
and apparent NMJ formation.16 However, skeletal muscle
3D tissue-engineered constructs have generally been inner-
vated in a poorly defined manner. Spontaneous myotube
contractions and advanced differentiation have been ob-
served as a result of culturing rodent spinal cord slices
within a 3D myoblast-seeded gel.17 Larkin and colleagues
engineered laminin-based skeletal muscle constructs and
cocultured them with spinal cord explants, witnessing some
alterations in myosin heavy chain expression and augmented
force production. Alternatively, engineered muscle con-
structs have been implanted in vivo in close proximity to
severed nerves causing the nerve to reattach to the muscle
construct,18,19 leading to improved contractile force pro-
duction following electrical stimulation. Recently, neural
stem cells have been cocultured in a systematic manner on
top of hydrogels seeded with the myogenic C2C12 cell line,
showing colocalization of NMJ proteins and responsiveness
to chemical neural stimulation20 and the addition of PC12
neural cells to C2C12’s improved levels of differentiation
and myogenic gene expression in 3D gelatin-based hydro-
gels.21 However, the development of a defined and isolated
3D tissue-engineered neuromuscular interface generated
from primary cells, which is structurally and physiologically
similar to the mammalian synapse, has yet to be established.
The aim of the present work was to isolate primary em-
bryonic rodent motor neurons and coculture them alongside
primary neonatal rodent myoblasts in an established tissue-
engineered skeletal muscle model,6,22 and subsequently
identify if NMJs were present and if the structure and
function of the construct were improved. Indeed, we dem-
onstrate in this study that the addition of motor neurons to
engineered skeletal muscle leads to observable neuromus-
cular interactions, which can be manipulated chemically,
suggesting the presence of NMJs. In addition, motor neuron
coculture leads to the generation of a muscle tissue more
similar to native skeletal muscle by virtue of improved
functionality and augmented myotube morphology. Models
such as this may be used to advance the understanding of
neuromuscular degeneration and diseases in the near future.
Materials and Methods
Isolation of primary muscle-derived cells
Primary muscle-derived cells (MDCs) were isolated from
neonatal (P1) Sprague-Dawley rats as previously described7
in accordance with the code of practice for the humane
killing of animals under Schedule 1 of the Animals (Scientific
Procedures) Act 1986. Briefly, skin was removed from the
hindlimbs of P1 pups and the underlying tissue transferred to
a Petri dish containing phosphate-buffered saline (PBS;
Sigma-Aldrich, Dorset, United Kingdom) supplemented with
2% penicillin (100 units/mL)/streptomycin (100mg/mL) (P/S)
(Gibco/Invitrogen, Paisley, United Kingdom). The muscle
tissue was separated from the bone, and the remaining muscle
tissue was suspended in a 0.1% collagenase solution (Gibco/
Invitrogen) and transferred to a shaking incubator set to
300 rpm for 50min, with occasional trituration by pipetting.
The resulting cell suspension was passed through a
100 mm and then a 40 mm mesh filter (BD Biosciences, East
Rutherford, NJ) to remove any debris or undigested tissue
fragments, before being spun at 480 g for 10min. The cells
were resuspended in 2mL growth medium (GM) consisting
of high glucose Dulbecco’s modified Eagle’s medium
(Gibco/Invitrogen), supplemented with 20% fetal bovine
serum (PAA, Somerset, United Kingdom), and 1% P/S.
To characterize the isolated cell population, primary
MDCs were plated on to 0.2% gelatin-coated coverslips at a
density of 10· 104 cells/cm2. Cells were fixed after 3 days in
culture and subsequently stained for the myogenic protein
Desmin (see immunohistochemistry). It was found that
32% – 5% of the isolated cells were myogenic in nature.
Isolation of primary mixed ventral horn-derived cells
Primary motor neurons were isolated from rat embryos at
gestational age E14. Pregnant Sprague-Dawley females
were euthanized by exposure to a rising concentration of
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carbon dioxide gas, in accordance with the code of practice
for the humane killing of animals under Schedule 1 of the
Animals (Scientific Procedures) Act 1986.
Embryos were removed following hysterectomy and
transferred to a Petri dish containing Hank’s balanced saline
solution (HBSS; Sigma-Aldrich) supplemented with 2%
P/S. Spinal cords were separated from the surrounding tissue
and the meninges carefully removed. The dorsal horn was
then cut away from the ventral portion of the spinal cord and
discarded. The ventral horns from individual embryos were
pooled and incubated in a 0.025% trypsin solution (type XII-
S; Sigma-Aldrich) in HBSS for 10min. They were then
transferred to a fresh solution containing 800 mL L-15 me-
dium (Gibco/Invitrogen), 100 mL 4% bovine serum albumin
(BSA; Sigma-Aldrich), and 100mL DNAse (1mg/mL;
Sigma-Aldrich). The spinal cords were agitated vigorously
until they had disaggregated and were then triturated and
left to settle. After 2min, the solution was transferred to a
15-mL centrifuge tube (care was taken to avoid transferring
any undissociated fragments). This process was repeated on
two more occasions, and the three supernatants were pooled
before being spun through a 1mL 4% BSA cushion for
5min at 370 g. Once the supernatant had been removed, the
pellet was resuspended in 1mL of complete neurobasal
medium (CNB) consisting of neurobasal medium (Gibco/
Invitrogen) supplemented with 2% B27 supplement (Gibco/
Invitrogen), 2% horse serum (PAA), 1% P/S, 0.1 ng/mL
glial cell derived neurotrophic factor (Alomone Labs, Jer-
usalem, Israel), 0.5 ng/mL ciliary neurotrophic factor (Alo-
mone Labs), 0.1 ng/mL brain derived neurotrophic factor
(Alomone Labs), 0.05% 2-mercaptoethanol (Gibco/Invitro-
gen), and 0.025% 200mM glutamine (Gibco/Invitrogen).
The isolated ventral horn-derived cells were plated on to
coverslips, which had previously been coated with 1.5mg/mL
polyornithine and 3mg/mL laminin, at a density of 37.5· 104
cells/cm2 to characterize the cell population. Cells were fixed
after 3 days and immunostained for MAP-2 (see immunohis-
tochemistry) as marker of neuronal commitment. It was found
that 35%–2% of the cell population were MAP-2 positive.
Tissue engineering 3D fibrin-based myotube–motor neuron
constructs
Fibrin gels were prepared as previously described.6
Briefly, two 6mm silk sutures were pinned into Sylgard-
coated 35-mm plates 12mm apart using 0.15mm minutien
pins (Entomoravia, Slavkov u Brna, Czech Republic). Plates
were sterilized by ultraviolet light and washing with 70%
ethanol and left to dry for 3 h. Each plate then received
500mL of GM containing 10U/mL thrombin (Sigma-
Aldrich) and 80mg/mL aprotinin (Sigma-Aldrich) which
was spread evenly over the surface of the plate ensuring the
sutures were fully covered. Two hundred microliters of
20mg/mL stock fibrinogen (Sigma-Aldrich) solution was
then added to the plate, and was agitated gently to ensure
even distribution and then left to incubate for 10min at
room temperature before being transferred to the incubator
(37C) for 1 h. Once the gel had set, 2 · 105 primary MDCs
were evenly plated on top of the gel surface in 2mL of GM
containing 0.25mg/mL 6-aminocaproic acid (Sigma-
Aldrich) to prevent fibrin degradation. Once MDCs within
the gels became confluent (typically 4 days of culture),
5 · 105 primary ventral horn cells were plated on to the gel
surface and allowed to attach for 10–15min before 2mL of
CNB supplemented with 0.25mg/mL 6-aminocaproic acid,
10 ng/mL insulin-like growth factor 1 (AbD Serotec, Ox-
ford, United Kingdom), and 200 ng/mL recombinant rat
Agrin (R&D Systems, Abingdon, United Kingdom) was
added. Culture medium was replaced every other day for the
duration of experimentation. It is of note that the time at
which ventral horn-derived cells were seeded on to the fibrin
gel (Fig. 1A) dictated that cells which adhered to the sub-
strate would be encapsulated within the fully formed 3D
construct (Fig. 1B), and, therefore, be in close proximity to
the myotubes throughout the core of the tissue.
Immunohistochemistry
Constructs were washed twice with PBS and then fixed
using ice-cold methanol and acetone. Subsequently, 3D
constructs were cut away from the sutures and placed on
polylysine-coated microscope slides (VWR, Leicestershire,
United Kingdom) and ringed with PAP pen (Dako, Cam-
bridgeshire, United Kingdom). Constructs were blocked
with 1· Tris-buffered saline (TBS; 0.5M) containing 5%
serum (Sigma-Aldrich) and 0.2% Triton X-100 (Fisher Sci-
entific, Leicestershire, United Kingdom) for 90min. Follow-
ing three washes with TBS, constructs were incubated
overnight with primary antibodies in a humidified staining
chamber. Myotubes and motor neurons were identified with
FIG. 1. Macroscopic images of
tissue-engineered skeletal muscle
constructs at 4 and 18 days in cul-
ture. (A) By 4 days in culture at the
time of motor neuron seeding the
gel has begun to self-assemble, but
still occupies a large surface area
allowing the neurons to attach. (B)
At the end of the culture period the
constructs are completely assem-
bled into a three-dimensional (3D)
structure, in which the motor neu-
rons and myotubes are encapsu-
lated. Scale bars = 10mm.
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mouse anti-Desmin (Clone D33; Dako) and rabbit anti-MAP-
2 (Millipore, Herefordshire, United Kingdom), respectively,
both diluted 1:200 in TBS. Presynaptic nerve terminals were
identified using antisynaptic vesicle protein-2 (SV-2; DSHB,
Iowa City, IA) diluted 1:10 in TBS. After overnight incuba-
tion, constructs were washed three times in TBS and incubated
for 3 h with goat anti-mouse AlexaFluor 488 and donkey anti-
rabbit AlexaFluor 568 secondary antibodies (Invitrogen) both
diluted 1:200 in TBS, and 4¢,6-diamidino-2-phenylindole
(DAPI; Sigma-Aldrich) to visualize nuclei. AChR’s were
stained using Texas red-conjugated a-Bungarotoxin (Sigma-
Aldrich) diluted 1:1000 during the secondary antibody incu-
bation. Following three further washes in distilled water,
constructs were mounted on glass coverslips using a drop of
Fluoromount (Sigma-Aldrich) mounting medium.
Three-dimensional constructs were imaged using a Zeiss
LSM-710 confocal microscope (Zeiss, Cambridgeshire,
United Kingdom) and were analyzed using ImageJ software
(NIH, Bethesda, MD). Fusion index was calculated as the
number of nuclei incorporated into myotubes expressed as a
percentage of the total number of Desmin-positive nuclei
and striated myotubes were considered to be those which
exhibited a striated pattern at any point along their length.
RNA extraction and real time polymerase chain reaction
Media was removed from plates and constructs were
washed twice with PBS before the addition of 500 mL of
TRIzol (Life Technologies, Paisley, United Kingdom).
Each construct was then homogenized and the RNA ex-
tracted according to the manufacturer’s instructions. Reac-
tions were prepared in triplicate in 96-well plates and
consisted of 70 ng of RNA diluted in 9.5 mL of nuclease-free
water, 0.15 mL of both forward and reverse primers at a final
concentration of 750 nM (see Table 1 for primer sequences),
0.2 mL of the QuantiFast Reverse Transcriptase Kit (Qiagen,
Crawley, United Kingdom), and 10mL of SYBR Green Mix
(Qiagen). Plates were transferred to an Mx3005P Thermal
Cycler for one-step RT-PCR, which was programmed to
perform the following: 10min at 50C (reverse transcrip-
tion), 5min at 95C (Hot Start Taq polymerase), followed
by 40 cycles of 95C for 10 s and 60C for 30 s. Fluores-
cence was detected at the end of each cycle and data were
analyzed using the 2(-DDCT) method using POLR2b as a
reference gene and a single aneurally cultured construct
from each experiment as a calibrator.
Evaluation of chemical inhibition of myotube contraction
One anchor from the fibrin construct to be analyzed was
removed from the Sylgard and attached to a model 403A
force transducer (Aurora Scientific, Dublin, Ireland) using
canning wax. The force transducer was connected to a
PowerLab 4/25T unit with associated software (ADInstru-
ments, Oxford, United Kingdom), and force generated by
the constructs was measured at 1 kHz. The baseline force
generated by the constructs (spontaneous twitch) was re-
corded for 60 s, before 100 mM d-tubocurarine (Abcam,
Cambridge, United Kingdom) was added to the medium
bathing the constructs. Recording continued after applica-
tion of the drug for up to 3min. Twitch frequency at base-
line and following the addition of d-tubocurarine was
generated from analyzing the initial 1min of force and the
second minute of contractile force following d-tubocurarine
treatment, respectively. The second minute of force after
d-tubocurarine addition was selected to discount any mea-
surement of construct movement due to the physical addi-
tion of the drug solution to the bath medium.
Assessment of muscle function by electrical stimulation
Constructs were washed twice in PBS and connected to a
force transducer as described above. Three milliliters of
Krebs–Ringer–Hepes (KRH; 10mM HEPES, 138mM
NaCl, 4.7mM KCl, 1.25mM CaCl2, 1.25mM MgSO, 5mM
glucose, 0.05% BSA in dH20) buffer solution was then
added to the dish containing the construct and two stainless
steel electrodes were placed in position either side of the
construct and submerged in the KRH buffer before func-
tional testing. Impulses were generated using LabVIEW
software (National Instruments, Berkshire, United King-
dom) connected to a custom-built amplifier. Data were ac-
quired using PowerLab software (ADInstruments) with a
sampling rate of 1 kHz.
Rheobase was calculated as the electric field strength
eliciting 50% peak twitch force with a 1.2ms pulse width,
and maximal tetanic force was determined using a 100Hz
impulse train at 3.5 V/mm. Time to peak twitch (TPT) was
defined as the amount of time taken for maximal twitch
force to raise from baseline to peak, and half relaxation
time (HRT) was the amount of time taken for the twitch
amplitude to fall by half at the cessation of stimulation.
Fatigue was tested by eliciting tetanic contractions at 50 Hz
for 3min with a 1 s rest between pulse trains, and the force
Table 1. Primer Sequences Used for Detection of Myosin Heavy Chain mRNA Levels
Target mRNA Primer sequence 5¢-3¢ NCBI reference
MYH3 F: CAAGTTCATCCGCATCCAT NM_012604.1
R: TCGTAAGGGTTGGTCGTAA
MYH8 F: TACGCCAGTGCTGAAGCAGGTA NM_001100485.1
R: CCATGGCACCGGGAGTTTTCG
MYH1 F: CCTAAAGGCAGACTCT
CCCACTGGG
NM_001135158.1
R: GGCCATCTCGGCGTCGGAAC
MYH7 F: AAGAAGGTGCGCATGGACCTGG NM_017240.2
R: CCTGCTCATCCTCAATCCTGGCG
POLR2b F: ACATAACGAAGACGGTCAT NM_001106002.1
R: TAAGCCATTCAACAAGCAATA
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decrement between the first and last contraction was
calculated.
Statistical analysis
All data are presented as mean – standard deviation, un-
less otherwise stated. Mann–Whitney U tests were used to
determine if statistical differences existed between con-
structs cultured with or without motor neurons. The results
of the chemical inhibition study were analyzed using a two-
way mixed measure ANOVA. All statistical analyses were
conducted using SPSS version 22.0.
Results
Motor neuron–myotube interactions
Immunohistochemical analysis of cocultured constructs
demonstrated uniaxial alignment of myotubes within the 3D
hydrogels in response to the mechanical cues generated by
the opposing anchor points. Furthermore, MAP-2 staining
of motor neurons confirmed the adherence of the ventral
horn-derived cells to the fibrin gel substrate, and neurites
extended away from the cell body in a manner characteristic
of this cell type (Fig. 2A). Interestingly, these neural pro-
jections were frequently observed extending toward myo-
tubes (Fig. 2A arrows), perpendicular to the alignment of the
majority of cellular structures, suggesting thatmyotube–motor
neuron interactions were occurring within the 3D constructs,
and these interactions could override the mechanical signals
inherent to the system.
FIG. 2. Primary myotubes and motor neurons coexist and
interact in 3D tissue-engineered constructs. (A) Immuno-
staining for Desmin (green) and MAP-2 (red) labels myo-
tubes and motor neurons, respectively, and shows uniaxial
alignment of myotubes and deviation of neurites toward the
myotubes. (B) Colocalization of acetylcholine receptor
(AChR; red) and synaptic vesicle protein-2 (SV-2; green)
marks the colocalization of pre- and postsynaptic membranes
on the myotube and motor neuron, respectively. Cells are
counterstained with 4¢,6-diamidino-2-phenylindole (DAPI;
blue). Scale bars= 50mm. Arrows indicate the deviation of
neurites away from the direction of mechanical signals.
FIG. 3. Chemical antagonism of the AChR using d-
tubocurarine indicates the presence of neuromuscular
interactions in tissue-engineered skeletal muscle–motor
neuron cultures. (A) Representative force trace showing
spontaneous twitch at baseline and in the presence of
100mM d-tubocurarine. (B) Twitch frequency is reduced by
the addition of d-tubocurarine only in cocultured constructs.
(C) Average force is reduced in cocultured constructs fol-
lowing the addition of d-tubocurarine, but not in aneural
constructs. Data are mean – standard deviation (SD) for n = 3
constructs in each condition. * Indicates a statistically sig-
nificant difference (p £ 0.05).
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To investigate this interaction further, immunostaining
for presynaptic (SV-2) and postsynaptic (AChR) structures
was conducted to observe colocalizations as an indica-
tion of potential NMJ formation. Colocalization between
SV-2 and AChR was found to occur (Fig. 2B), suggesting
that there was putative NMJ formation within cocultured
fibrin constructs, despite the frequency of interaction being
relatively low (0.22 – 0.06/mm2). No SV-2 staining was
detected in constructs cultured in the absence of motor
neurons.
Chemical inhibition of contractile activity
Following 18 days of culture (14 days coculture), no
statistically significant difference existed in spontaneous
myotube twitch amplitude ( p = 0.22) or frequency ( p = 0.10)
between muscle constructs cultured with or without motor
neurons (Fig. 3B, C), although the mean amplitude and
frequency tended to be higher in cocultured constructs. The
addition of the neuromuscular blocking agent d-
tubocurarine, however, caused reductions in both twitch
frequency (interaction effect p£ 0.05) and twitch amplitude
(interaction effect p = 0.07) only in those constructs which
were cultured with motor neurons (Fig. 3A–C). This sug-
gests that there is a degree of functional synaptic contact in
the myotube–motor neuron constructs, which can be ma-
nipulated chemically.
Electrically evoked contractile properties
Electrical field stimulation was utilized to investigate the
effect of neuronal presence on the contractile characteristics
of engineered skeletal muscle. After 18 days in vitro, con-
structs cultured with motor neurons exhibited*145% greater
twitch force when maximally stimulated compared to aneural
controls (3.07– 0.70mN vs. 1.25– 0.61mN, p£ 0.05, Fig.
4A, B). Similarly, when a 1 s pulse train was delivered to the
constructs to evoke a fused tetanic contraction, force pro-
duction was augmented by *143% in cocultured constructs
in comparison to constructs cultured in the absence of neu-
rons (4.16– 1.14mN vs. 1.71– 0.85mN, p£ 0.05, Fig. 4C,
D), thus clearly indicating a positive effect of motor neuron
coculture on the ability of skeletal muscle constructs to
maximally contract.
Rheobase was used as a measure of muscle excitability, and
did not appear to differ between constructs cultured in the
presence or absence of motor neurons (0.40– 0.15V/mm vs.
0.25– 0.13V/mm, p= 0.15) suggesting that motor neurons did
not affect this aspect of muscle function. HRT was, however,
significantly increased by the addition of motor neurons to
skeletal muscle 3D constructs (339– 46ms vs. 222– 14ms,
p£ 0.05, Fig. 5A). Similarly, TPT was also somewhat affected
by the addition of motor neurons and measured 282– 27ms
compared to aneural controls that measured 222– 66ms,
which although failed to reach statistical significance, re-
presented a substantial effect ( p= 0.20, r= 0.45, Fig. 5A). As
such, motor neuron–myotube constructs appear to display a
slowing of the contractile kinetics in comparison to constructs
cultured in the absence of motor neurons.
To determine if the slowed twitch kinetics were matched by
improvements in fatigue resistance (characteristics of a slow
muscle) a 3-min fatigue test was conducted on constructs
cultured in the presence and absence of motor neurons.
FIG. 4. Contractility of tissue-engineered skeletal muscle is improved by coculture with motor neurons. (A, B) Twitch
force is augmented by coculture with motor neurons. (C, D) Maximal isometric force is greater when myotubes are
cocultured alongside motor neurons. Data are mean – SD for n = 3 constructs in each condition. * Indicates statistically less
than +MN ( p £ 0.05).
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However, the reductions in force over the course of the test
were similar between conditions, with innervated constructs
displaying a 35.35%– 8.56% loss of force compared to a
39.35%– 6.64% loss of force in aneural constructs ( p= 0.50,
Fig. 5B).
mRNA expression of myosin heavy chain isoforms
Since we observed some slowing of the contractile prop-
erties (HRT and TPT) when myotubes were cocultured with
motor neurons, we looked to see if the expression of myosin
heavy chain isoforms were altered in these constructs in
comparison to controls (Fig. 6). Interestingly, we found that
mRNA levels of MYH3 and MYH8, which correspond to em-
bryonic and neonatal isoforms, respectively, were significantly
reduced in cocultured constructs (MYH3: 1.02– 0.08 aneural
vs. 0.70– 0.21 innervated, MYH8: 0.94– 0.15 aneural vs.
0.62– 0.18 innervated, both p£ 0.05) after 18 days in culture/
14 days coculture. There was also a somewhat reduced ex-
pression of the fast isoform MYH1 that measured 0.73–
0.27 in innervated constructs compared to 0.96– 0.23 in an-
eural constructs, which although did not reach significance,
represented a marked effect ( p= 0.09, r= 0.44). However,
expression of the slow isoform MYH7 was maintained in
cocultured constructs (0.97– 0.04 aneural vs. 0.88– 0.14
innervated, p= 0.12) This could indicate that myotubes cul-
tured in the presence of motor neurons became slower in na-
ture by virtue of maintenance of slow myosin heavy chain
expression and concomitant reductions in all other isoforms.
Myotube morphology
To determine if any of the contractile differences observed
between constructs cultured with or without motor neurons
was due to alterations in morphology of the myotubes, 18-day-
old constructs were immunostained for the cytoskeletal inter-
mediate filament Desmin. Fusion index did not differ between
innervated or aneural constructs (90.11– 2.89 vs. 90.17– 7.49,
respectively, p= 0.35, Fig. 7A) and no difference existed in
myotube number in each condition (14.87– 2.84 vs. 14.80–
1.11myotubes per microscope frame in innervated and aneural
cultures, respectively, p= 0.50) showing that the overall levels
of differentiation were independent of neural input. Further-
more, myotube width, as an indicator of hypertrophy, was
similar between conditions; with cocultured myotubes mea-
suring 7.44– 0.20mm and aneurally cultured myotubes mea-
suring 8.06– 0.59mm ( p= 0.10, Fig. 7B). Strikingly, however,
myotubes cocultured in 3D with motor neurons consistently
presented with striations, whereas this striated pattern was rare
in aneurally cultured myotubes. Indeed, when quantified,
84.42%– 7.85% of myotubes were striated in the 3D co-
cultured constructs compared with only 13.90%– 4.47% of
myotubes in the aneural constructs ( p£ 0.05, Fig. 7C). As such
it appears that the presence of motor neurons has a maturation
effect on myotubes in 3D hydrogels.
Discussion
Neuromuscular disorders which impact upon both the
motor neuron and skeletal muscle can lead to significant loss
of muscle function and are often fatal.2 While there is much
ongoing research in this area, there is a need to develop new
methodologies that can reduce the reliance on animal use
and accurately resemble the in vivo physiology of the
FIG. 5. The addition of motor neurons to engineered
skeletal muscle constructs effects markers of muscle phe-
notype. (A) Time to peak twitch and half relaxation time are
increased in cocultured versus aneural constructs. (B) Force
decrement over a 3-min fatigue test was unaffected by the
addition of motor neurons to engineered skeletal muscle.
Data are mean – SD for n= 3 constructs in each condition.
* Indicates a statistically significant difference ( p £ 0.05).
FIG. 6. The mRNA expression of myosin heavy chain
isoforms in 3D tissue-engineered skeletal muscle cultured in
the presence or absence of motor neurons. Innervated con-
structs displayed reduced levels of MYH3 (embryonic) and
MYH8 (perinatal) compared to aneural controls. The adult
isoforms MYH1 (fast) and MYH7 (slow) not statistically
different between groups. Data are mean – SD for n = 8
constructs in each condition. * Indicates a statistically sig-
nificant difference ( p £ 0.05).
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neuromuscular interface. Tissue-engineered skeletal muscle
has been consistently reported to exhibit structural and
functional similarities to the native tissue8; however its in-
tegration with the peripheral nervous system has been
scarcely studied. Indeed, the generation of an engineered
tissue with NMJs would be a useful tool for physiologists
and an ideal test bed to study neuromuscular therapeutics. In
the present work we have produced an innervated 3D
skeletal muscle from primary cells, which exhibits neuro-
muscular interactions, responsiveness to NMJ inhibitors,
improved contractile function, and enhanced morphology,
and as such represents significant advancement toward a
fully integrated engineered in vitro skeletal muscle.
The attachment of embryonic rodent motor neurons to
engineered skeletal muscle constructs was confirmed by
immunostaining for MAP-2. Morimoto et al. recently
identified that the addition of neurons to a 3D construct can
be difficult since the cells can slip away from its surface. In
the present work, the use of an established self-assembling
tissue engineering method allowed the cells to attach to the
substrate before it fully assembled, thereby contributing to
improved cell attachment and allowing the motor neurons to
be incorporated into the 3D scaffold. Furthermore, while the
majority of MAP-2-positive cells adopted a longitudinal
orientation within the constructs, frequently the neural ex-
tensions were seen tracking perpendicular to the lines of
tension toward the myotubes (Fig. 1A). This differs from the
data of Morimoto et al. who conducted alignment analysis
on both myotubes and the cocultured neural stem cells, and
showed that both cell types maintained longitudinal orienta-
tion. As such it appears that in the 3D myotube–motor neuron
constructs described in this study, neurotrophic factors may
predominate over mechanical signals, in turn encouraging
neuromuscular interactions.
The utility of an engineered myotube–motor neuron
construct is highly dependent upon the presence of func-
tional NMJs. Identification of colocalized pre-and postsyn-
aptic proteins in our models suggests that the interactions
between motor neurons and myotubes did indeed result in
NMJ formation. Furthermore, the addition of the AChR
antagonist d-tubocurarine to the media bathing the con-
structs led to a reduction in twitch force and frequency in
cocultured constructs, providing further evidence of func-
tional NMJ formation in this model. Interestingly, sponta-
neous myotube twitch in aneural myotubes has previously
been attributed to autocrine activation of AChR’s by an
ACh-like compound secreted by skeletal muscle myo-
tubes.23 However, the present data, which show an effect of
AChR blockade solely in constructs cocultured with motor
neurons, perhaps suggests alternate mechanisms regulating
spontaneous twitch in aneural and innervated myotubes,
although the present study did not aim to elucidate these
FIG. 7. The presence of
motor neurons in engineered
skeletal muscle improves the
myotube structure, but does
not enhance levels of differ-
entiation. Constructs im-
munostained for Desmin
reveal that fusion index (A)
and myotube width (B) are
not influenced by the addi-
tion of motor neurons to 3D
myotube cultures. However,
the percentage of striated
myotubes (C) is enhanced in
cocultured versus aneural
constructs. Cells are coun-
terstained with DAPI (blue).
Data are mean – SD for n = 3
constructs in each condition.
* Indicates statistically less
than +MN ( p £ 0.05). Scale
bars = 50 mm.
2602 MARTIN ET AL.
mechanisms. Putative NMJs have been previously described
in 3D constructs as assessed by colocalized proteins18,24 and
chemical contractile inhibition.20 However, this is the first
report which has generated a 3D innervated skeletal muscle
in a systematic, controllable manner utilizing primary cells.
As such, this presents a significant advancement toward the
utility of such a model in preclinical, physiological, and
pharmaceutical testing.
It has previously been established that external electrical
stimulation of myotubes in 3D constructs similar to those
described in this study augments contractile force produc-
tion.25 Similarly, coculture of 3D skeletal muscle constructs
with spinal cord explant or implantation of engineered
muscle in close proximity to severed nerves in vivo results
in enhanced isometric tetanic force.18,19,24 In the present
work both peak twitch and peak tetanic force were enhanced
by the addition of motor neurons to skeletal muscle con-
structs, with peak force generation averaging*4mN, more
than an order of magnitude greater than the forces previ-
ously described in this or similar models.24,26–28 Thus, the
addition of motor neurons to engineered skeletal muscle
drives the maturation of the tissue, and results in a func-
tional response closer to that of native skeletal muscle.
We further investigated the functional properties of the
innervated constructs by assessing TPT, HRT, and rheobase
as a measure of excitability. While the excitability of the
tissue and TPT did not change, the HRT was significantly
slowed in those constructs cocultured with motor neurons,
suggesting that these constructs may have switched to a
slow phenotype. Since slow muscles are fatigue resistant,
we conducted a 3-min fatigue test on constructs cultured
with or without motor neurons and found that the loss of
force over the course of the test did not differ between
conditions. In embryonic muscle development slow myosin
heavy chain expression is lost when innervation is chemi-
cally ablated,11 and in cell culture models slow myosin
heavy chain expression is dependent upon coculture with
spinal cord explants.29 We, therefore, also conducted RT-
PCR for myosin heavy chain isoforms in cocultured and
aneurally cultured 3D skeletal muscle constructs. This
analysis showed reduced expression of the developmental
isoforms MYH3 and MYH8, alongside small reductions in
the fast isoform MYH1, with no observable changes in the
slow isoform MYH7. This suggests that skeletal muscle
constructs cultured with motor neurons may lose expression
of more immature isoforms, while maintaining slow myosin
heavy chain expression. Thus, overall analysis of the func-
tional and mRNA data suggests that coculture of myotubes
with motor neurons resulted in some features of a slow
muscle, but this transformation was incomplete.
Since neural innervation during development can impact
upon myotube size, number, and maturation,9–11 we finally
sought to determine whether the presence of motor neurons in
3D skeletal muscle constructs effected myotube morphology,
which may in turn explain the differences observed in con-
tractile force generation. Interestingly, the presence of motor
neurons had no effect on muscle precursor cell fusion nor did
it induce any hypertrophic effect on the myotubes. However,
Desmin immunostaining revealed a striated pattern in*85%
of myotubes, which were cocultured alongside motor neu-
rons while aneural cultures exhibited striations in only*13%
of myotubes. Indeed, it has previously been shown that
electrical stimulation can enhance the striations in C2C12
myoblasts cultured on electrospun scaffolds,30 and re-
cently coculture of C2C12’s with the PC12 neural cell line
improved the levels of differentiation and myosin heavy
chain mRNA expression in 3D hydrogels.21 It, therefore,
seems likely that the presence of motor neurons induced a
maturation effect on the myotubes through enhanced cy-
toskeletal organization, which in turn is responsible, at
least in part, for the improved force generation in these
constructs.
Conclusions
The development of tissue-engineered skeletal muscle
constructs, which have integration of motor neurons, would
exhibit great utility in the understanding of neuromuscular
diseases and as a preclinical test bed to study the use of
neuromuscular pharmaceuticals. In this study we have
generated such a model using primary cells cocultured in a
3D fibrin-based hydrogel which exhibits characteristics in-
dicative of NMJ formation and enhanced myotube matura-
tion, and presents a significant step forward in the formation
of fully integrated engineered skeletal muscle.
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